David Mountcastle - 01 Apr 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: EVP & Chief Financial Officer
Signature: /s/ Thomas Bartrum, as attorney-in-fact __________________________
Issuer symbol: PRVA
Transactions as of: 01 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Apr 2022, 08:53:37 UTC
Previous filing: 20 Dec 2022
Next filing: 30 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, $0.01 par value per share	Award	$0	+48,833	+151%	$0.000000	81,104	01 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVA	Stock Option (Right to Purchase)	Award	$0	+64,882		$0.000000	64,882	01 Apr 2022	Common Stock	64,882	$26.73	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 1, 2022, the reporting person received 48,833 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.
F2	On April 1, 2022, the reporting person received 64,882 stock options under the Issuer's 2021 Omnibus Incentive Plan. The stock options will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.